Random

FDA

Scott Gottlieb’s FDA Legacy

Scott Gottlieb’s FDA Legacy

FDA Drug Recalls and Warnings: Atorvastatin

FDA Drug Recalls and Warnings: Atorvastatin; Labeling Mix-Up with Muscle Relaxant Cyclobenzaprine, and More

FDA side effect update, Depo Provera

FDA SIDE EFFECTS UPDATE: Depo Provera and Brain Tumors, Veozah Boxed Warning And More

Q&A: Dr. Robert Blankfield Challenges the FDA on Safety

Q&A: A Doctor Challenges the FDA on Safety

The Problem With Weed

The Problem With Weed

Suzanne B. Robotti

Breast Implants: Should They Be Banned?

Breast Implants: Should They Be Banned?

Rachel Brummert

Issues Related to Healthcare News FDA

FDA warns of heart risk for many common pain relievers

FDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly

FDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly

Issues Related to Healthcare Health Pulse FDA

Has Government Shutdown Impacted Drug Safety?

Issues Related to Healthcare News FDA Watch Diabetes News FDA

FDA Issues Warning on Common Diabetes Drugs

FDA Requiring Long-Term Research of OxyContin Use

FDA Requiring Long-Term Research of OxyContin Use

Suzanne B. Robotti

New Antibiotics Might Speed Thru FDA

New Antibiotics Might Speed Thru FDA

Medshadow Staff

Prescription Drug Advertising May Soon Come to Twitter

Prescription Drug Advertising May Soon Come to Twitter

man inspecting drug manufacturing lab

Unannounced Inspections of Drug Manufacturers Could Improve Drug Safety — If It Actually Happens

2018: A MedShadow Year in Review

MedShadow Articles

2018: A MedShadow and FDA Year in Review

Hangover Treatment Side Effects

FDA Committees Wary of OTC Hangover Remedy

Is That New Drug Better? A Comparative Look

Tests and Testing Health Pulse FDA

Is That New Drug Better? A Comparative Look

FDA Warnings About Fluoroquinolone Antibiotics

FDA Warnings About Fluoroquinolone Antibiotics

Warning: Drug Ads May Cause Confusion

Healthy Skeptic 2

Warning: Drug Ads May Cause Confusion

Suzanne B. Robotti

FDA’s Black Box Warning for Xeljanz Leaves Patients, Doctors Scratching Their Heads

FDA’s Black Box Warning for Xeljanz Leaves Patients, Doctors Scratching Their Heads

Load More

x

x